Maxim Group analyst Nehal Chokshi maintained a Buy rating on BIO-key International Inc (BKYI) on July 24 and set a price target of $2.25. The company’s shares closed on Friday at $1.21.
According to TipRanks.com, Chokshi is a 4-star analyst with an average return of 6.5% and a 52.3% success rate. Chokshi covers the Consumer Goods sector, focusing on stocks such as Hewlett Packard Enterprise, Super Micro Computer, and Palo Alto Networks.
BIO-key International Inc has an analyst consensus of Moderate Buy, with a price target consensus of $2.25.
See today’s analyst top recommended stocks >>
The company has a one-year high of $2.23 and a one-year low of $0.75. Currently, BIO-key International Inc has an average volume of 10.31K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
BIO-key International, Inc. is engaged in the development and market of fingerprint biometric technology and related security software solutions. It offers identification and verification solutions, such as personal inspection identification, passwords, tokens, smart cards, ID cards, PKI, credit card, passports, driver’s licenses, and OTP or other form of possession or knowledge-based credentialing. It also delivers identification solutions and information services to commercial, government, law enforcement and prison markets. The company was founded on January 7, 1993 and is headquartered in Wall, NJ.
